UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008079
Receipt number R000009515
Scientific Title The safety and efficacy of Bisoprolol in patient with ischemic heart disease complicating chronic obstructive pulmonary disease
Date of disclosure of the study information 2012/06/01
Last modified on 2020/02/16 06:40:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The safety and efficacy of Bisoprolol in patient with ischemic heart disease complicating chronic obstructive pulmonary disease

Acronym

The safety and efficacy of Bisoprolol in COPD patient

Scientific Title

The safety and efficacy of Bisoprolol in patient with ischemic heart disease complicating chronic obstructive pulmonary disease

Scientific Title:Acronym

The safety and efficacy of Bisoprolol in COPD patient

Region

Japan


Condition

Condition

The patient with ischemic heart disease complicating chronic obstructive pulmonary disease

Classification by specialty

Cardiology Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the safety and efficacy of Bisoprolol in patient with ischemic heart disease complicating chronic obstructive pulmonary disease

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Respiratory function after 9 months intervention

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Bisoprolol, maintenance dose of 5mg/day (allowed to be started with 0.625mg/day according to the condition of the patient), for 9 months

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The ischemic heart disease patient with chronic obstructive respiratory disease (COPD) defined in COPD clinical guideline of Japanese Respiratory Society

Key exclusion criteria

The patient with contraindication of Bisoprolol.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yoshiyuki
Middle name
Last name Furuse

Organization

Tottori University

Division name

Faculty of Medicine, Department of Molecular Medicine and Therapeutics

Zip code

6838504

Address

36-1 Nishimachi, Yonago, 683-8504, Japan

TEL

0859-38-6517

Email

yfuruse-circ@umin.ac.jp


Public contact

Name of contact person

1st name Yoshiyuki
Middle name
Last name Furuse

Organization

Tottori University

Division name

Faculty of Medicine, Department of Molecular Medicine and Therapeutics

Zip code

6838504

Address

36-1 Nishimachi, Yonago, 683-8504, Japan

TEL

0859-38-6517

Homepage URL


Email

yfuruse-circ@umin.ac.jp


Sponsor or person

Institute

Tottori University Faculty of Medicine, Department of Molecular Medicine and Therapeutics

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Faculty of Medicine, Department of Molecular Medicine and Therapeutics, Tottori University

Address

36-1 Nishimachi, Yonago, 683-8504, Japan

Tel

0859-38-6517

Email

yfuruse-circ@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

鳥取大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2012 Year 06 Month 01 Day


Related information

URL releasing protocol

https://www.umin.ac.jp/ctr/index.htm

Publication of results

Unpublished


Result

URL related to results and publications

https://www.umin.ac.jp/ctr/index.htm

Number of participants that the trial has enrolled

50

Results

The trial was closed due to lack of applicants.

Results date posted

2020 Year 02 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The trial was closed due to lack of applicants.

Participant flow

The trial was closed due to lack of applicants.

Adverse events

The trial was closed due to lack of applicants.

Outcome measures

The trial was closed due to lack of applicants.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 06 Month 01 Day

Date of IRB

2012 Year 05 Month 31 Day

Anticipated trial start date

2012 Year 06 Month 01 Day

Last follow-up date

2016 Year 09 Month 01 Day

Date of closure to data entry

2016 Year 12 Month 01 Day

Date trial data considered complete

2016 Year 12 Month 01 Day

Date analysis concluded

2017 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 06 Month 01 Day

Last modified on

2020 Year 02 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009515


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name